[VRDN] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
09-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -51.66%
YoY- -46.84%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 72 72 98 105 1,195 256 216 -51.89%
PBT -47,660 -55,063 -68,151 -45,785 -28,905 -29,491 -25,693 50.91%
Tax -135 4,378 -105 -3,281 -880 227 -196 -21.98%
NP -47,660 -55,063 -68,046 -42,504 -28,025 -29,491 -25,497 51.68%
Tax Rate - - - - - - - -
Total Cost 47,732 55,135 68,144 42,609 29,220 29,747 25,713 50.98%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -66,194.44 -76,476.39 -69,434.69 -40,480.00 -2,345.19 -11,519.92 -11,804.17 215.30%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -1.09 -1.27 -1.61 -1.05 -0.83 -1.06 -0.98 7.34%
EPS Diluted -1.09 -1.27 -1.61 -1.05 -0.83 -1.06 -0.98 7.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.